SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Bough Bonin | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Calantzopoulos Andre | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Combes Michel | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Geissler Werner | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Harker Victoria D | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Hook Lisa | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Morparia Kalpana | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Polet Robert | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Yanai Shlomo | Director | 2026-05-06 | Grant/award | 1119 | $190K |
| Dobrowolski Reginaldo | Group Controller | 2026-03-06 | Tax withholding | 22 | $4K |
| Dobrowolski Reginaldo | Group Controller | 2026-02-20 | Open-market sell | 5000 | $917K |
| Dobrowolski Reginaldo | Group Controller | 2026-02-20 | Open-market sell | 1000 | $184K |
| Kennedy Stacey | CEO PMI U.S. | 2026-02-20 | Open-market sell | 14350 | $2.6M |
| Babeau Emmanuel | Group Chief Financial Officer | 2026-02-19 | Open-market sell | 33800 | $6.1M |
| De Wilde Frederic | CEO PMI International | 2026-02-19 | Open-market sell | 20000 | $3.7M |
| Guerin Yann | Group Chief Legal Officer | 2026-02-19 | Open-market sell | 4000 | $727K |
| Olczak Jacek | Group CEO PMI, Director | 2026-02-19 | Open-market sell | 80000 | $14.6M |
| Babeau Emmanuel | Group Chief Financial Officer | 2026-02-18 | Tax withholding | 2228 | $407K |
| Calantzopoulos Andre | Director | 2026-02-18 | Tax withholding | 14740 | $2.7M |
| De Wilde Frederic | CEO PMI International | 2026-02-18 | Tax withholding | 1000 | $183K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
Regulatory and operational risks broadened materially, with SFP-specific restrictions shifting from prospective to realized harm and new disclosures spanning AI/cybersecurity, third-party compliance, and supply chain concentration. No solvency or going-concern signals, but the expansion across five distinct themes — regulatory, technology, operations, and macro — represents a substantive widening of the disclosed risk perimeter. The cumulative picture reflects a company navigating an increasingly hostile and complex external environment for smoke-free products.
5 company-specific · 3 common-mode
New disclosure of WHO/FCTC guidance threatening SFP availability and access to product information; added specific regulatory risk (food classification bans) and expanded scope of restrictions to SFPs, not just combustibles.
Our business faces significant governmental actions aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco or nicotine-containing products.…
Risk escalated: shift from hypothetical concern to concrete evidence that some jurisdictions have already adopted unfavorable SFP taxation regimes, plus new mention of retroactive application risk.
We may be unsuccessful in our efforts to differentiate smoke-free products and cigarettes with respect to taxation. To date, we have been largely successful in demonstrating to regulators that our…
Removed detailed WHO/FCTC regulatory timeline and CoP 10 outcome; added language that regulatory restrictions "have" already limited commercialization, escalating from prospective to realized harm.
We may be unsuccessful in our efforts to introduce, commercialize, and grow smoke-free products in existing and new markets, and regulators may prohibit or significantly restrict the…
Added substantial new risk: third-party non-compliance with standards (quality, marketing, data protection, labor) could cause operational disruptions, legal/regulatory liabilities, reputational damage, or financial losses. Materially expands disclosed risk scope.
Use of third-parties may negatively impact the distribution, quality, and availability of our products and services, and we may be required to replace third-party contract distributors, manufacturers…
New disclosure of supply chain concentration risk: majority tobacco sourced directly from farmers rather than commodity markets, creating vulnerability to farmer exit, crop quality degradation, and regulatory/reputational risks if livelihoods disrupted.
Government mandated prices, production control programs, and shifts in crops driven by economic conditions may increase the cost or reduce the quality of tobacco and other agricultural products used…
Newly disclosed comprehensive risk covering GDPR, AI, data protection, and cybersecurity compliance across jurisdictions. Explicitly cites material adverse effect, substantial fines, and reputational harm.
Our or our business partners’ failure or inability to adhere to privacy, data, artificial intelligence and information security laws could result in reputational harm, legal liability, and…
New disclosure of material AI risks: operational disruptions, data loss, cybersecurity vulnerabilities, regulatory/litigation exposure, and reputational harm from flawed AI systems.
We increasingly use artificial intelligence-based solutions in our business, which could result in reputational harm, legal liability, and adversely affect our operating results. We and our business…
Added explicit risks from geopolitical boycotts, trade bans, and tariff volatility. Shifted from specific Ukraine/Middle East examples to broader, forward-looking trade and consumer preference risks.
Because we have operations in numerous countries, our results may be adversely impacted by economic, regulatory and political developments, natural disasters, pandemics or conflicts. Some of the…
PMI furnished a press release (Exhibit 99.1) disclosing updated 2026 full-year and Q3 diluted EPS forecasts, raising the full-year adjusted diluted EPS guidance range to $8.35–$8.50 (representing 10.7%–12.7% growth versus 2025). Although this is a guidance update rather than final results, it constitutes a material earnings disclosure furnished in connection with a conference presentation, consistent with Item 7.01 Regulation FD Disclosure practice for earnings-related announcements.
View raw filing on EDGAR →PMI announced entry into a contract manufacturing arrangement with Philip Morris USA (Altria subsidiary) for combustible cigarettes, with first shipments expected in early 2027. This is a material operational/strategic partnership involving manufacturing collaboration between two major tobacco companies, but does not fit the specific categories of M&A activity, debt issuance, or other defined event types. The arrangement represents a significant business development that would affect investor assessment of PMI's operational strategy and revenue streams.
View raw filing on EDGAR →Philip Morris International issued a press release on July 22, 2026 announcing its financial results for Q2 and first half-year ended June 30, 2026. The disclosure includes detailed results of operations with net revenues of $11.2 billion, adjusted diluted EPS of $2.20 (up 15.2%), and updated 2026 full-year guidance. This is a standard quarterly earnings release filed under Item 2.02 with exhibits containing the earnings announcement and supporting financial data.
View raw filing on EDGAR →Emmanuel Babeau, the Group Chief Financial Officer, is departing his executive role effective August 1, 2026, though he will remain employed as Strategic Advisor through March 31, 2027. The disclosure centers on his separation from the CFO position and the associated severance and compensation arrangements, including a lump-sum severance payment of CHF 1,260,012, continued base salary through the separation date, and full vesting of equity awards. While the filing also mentions Massimo Andolina's appointment as replacement CFO, the primary focus and substance of the disclosure is Babeau's departure and the material separation terms.
View raw filing on EDGAR →Philip Morris announced a regular quarterly dividend of $1.47 per share via press release on June 11, 2026, disclosed under Item 7.01 (Regulation FD Disclosure). While dividend declarations are routine corporate actions, they are material to shareholders as they affect total shareholder return and cash flow expectations. This does not fit the earnings_release category (which typically reports financial results) nor any other specific event type in the taxonomy, making other_material the most appropriate classification.
View raw filing on EDGAR →The Board approved the appointment of Massimo Andolina as Group Chief Financial Officer, effective August 1, 2026, succeeding Emmanuel Babeau. This C-suite appointment is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →